Logo image of BX

BLACKSTONE INC (BX) Stock Fundamental Analysis

NYSE:BX - US09260D1072 - Common Stock

169.32 USD
+1.98 (+1.18%)
Last: 9/4/2025, 12:32:59 PM
Fundamental Rating

5

Taking everything into account, BX scores 5 out of 10 in our fundamental rating. BX was compared to 239 industry peers in the Capital Markets industry. BX has an excellent profitability rating, but there are concerns on its financial health. BX is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year BX was profitable.
In the past year BX had a positive cash flow from operations.
BX had positive earnings in each of the past 5 years.
In the past 5 years BX always reported a positive cash flow from operatings.
BX Yearly Net Income VS EBIT VS OCF VS FCFBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

With a decent Return On Assets value of 6.31%, BX is doing good in the industry, outperforming 79.08% of the companies in the same industry.
Looking at the Return On Equity, with a value of 34.29%, BX belongs to the top of the industry, outperforming 96.65% of the companies in the same industry.
BX has a better Return On Invested Capital (17.66%) than 92.89% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BX is significantly above the industry average of 7.59%.
The last Return On Invested Capital (17.66%) for BX is above the 3 year average (12.81%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.31%
ROE 34.29%
ROIC 17.66%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
BX Yearly ROA, ROE, ROICBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

BX has a Profit Margin (20.83%) which is in line with its industry peers.
BX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 50.95%, BX belongs to the top of the industry, outperforming 85.77% of the companies in the same industry.
BX's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 50.95%
PM (TTM) 20.83%
GM N/A
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
BX Yearly Profit, Operating, Gross MarginsBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The number of shares outstanding for BX has been increased compared to 1 year ago.
BX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BX has been reduced compared to a year ago.
BX Yearly Shares OutstandingBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BX Yearly Total Debt VS Total AssetsBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 3.94 indicates that BX is not in any danger for bankruptcy at the moment.
The Altman-Z score of BX (3.94) is better than 81.59% of its industry peers.
The Debt to FCF ratio of BX is 3.66, which is a good value as it means it would take BX, 3.66 years of fcf income to pay off all of its debts.
BX has a better Debt to FCF ratio (3.66) than 74.90% of its industry peers.
BX has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
BX has a worse Debt to Equity ratio (1.44) than 69.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 3.66
Altman-Z 3.94
ROIC/WACCN/A
WACCN/A
BX Yearly LT Debt VS Equity VS FCFBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 0.70 indicates that BX may have some problems paying its short term obligations.
BX has a worse Current ratio (0.70) than 67.36% of its industry peers.
BX has a Quick Ratio of 0.70. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.70, BX is doing worse than 66.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.7
BX Yearly Current Assets VS Current LiabilitesBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.31% over the past year.
The Earnings Per Share has been growing by 14.97% on average over the past years. This is quite good.
BX shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.33%.
BX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.51% yearly.
EPS 1Y (TTM)25.31%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%26.04%
Revenue 1Y (TTM)33.33%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%22.18%

3.2 Future

The Earnings Per Share is expected to grow by 12.53% on average over the next years. This is quite good.
BX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.92% yearly.
EPS Next Y12.05%
EPS Next 2Y20.43%
EPS Next 3Y21.88%
EPS Next 5Y12.53%
Revenue Next Year9.27%
Revenue Next 2Y18%
Revenue Next 3Y19.89%
Revenue Next 5Y15.92%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BX Yearly Revenue VS EstimatesBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BX Yearly EPS VS EstimatesBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 33.86, which means the current valuation is very expensive for BX.
Compared to the rest of the industry, the Price/Earnings ratio of BX indicates a slightly more expensive valuation: BX is more expensive than 72.80% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BX to the average of the S&P500 Index (26.84), we can say BX is valued slightly more expensively.
BX is valuated quite expensively with a Price/Forward Earnings ratio of 25.16.
65.27% of the companies in the same industry are cheaper than BX, based on the Price/Forward Earnings ratio.
BX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.48, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.86
Fwd PE 25.16
BX Price Earnings VS Forward Price EarningsBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BX is valued a bit cheaper than 64.44% of the companies in the same industry.
BX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 61.15
EV/EBITDA 29.5
BX Per share dataBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BX has a very decent profitability rating, which may justify a higher PE ratio.
BX's earnings are expected to grow with 21.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.81
PEG (5Y)2.26
EPS Next 2Y20.43%
EPS Next 3Y21.88%

4

5. Dividend

5.1 Amount

BX has a Yearly Dividend Yield of 2.59%. Purely for dividend investing, there may be better candidates out there.
BX's Dividend Yield is comparable with the industry average which is at 7.91.
Compared to an average S&P500 Dividend Yield of 2.32, BX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.59%

5.2 History

On average, the dividend of BX grows each year by 11.16%, which is quite nice.
BX has paid a dividend for at least 10 years, which is a reliable track record.
BX has decreased its dividend recently.
Dividend Growth(5Y)11.16%
Div Incr Years1
Div Non Decr Years1
BX Yearly Dividends per shareBX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

182.75% of the earnings are spent on dividend by BX. This is not a sustainable payout ratio.
The dividend of BX is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP182.75%
EPS Next 2Y20.43%
EPS Next 3Y21.88%
BX Yearly Income VS Free CF VS DividendBX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BX Dividend Payout.BX Dividend Payout, showing the Payout Ratio.BX Dividend Payout.PayoutRetained Earnings

BLACKSTONE INC

NYSE:BX (9/4/2025, 12:32:59 PM)

169.32

+1.98 (+1.18%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-15 2025-10-15/amc
Inst Owners70.15%
Inst Owner Change12.98%
Ins Owners0.82%
Ins Owner Change5.05%
Market Cap200.59B
Analysts76.77
Price Target186.45 (10.12%)
Short Float %1.53%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield 2.59%
Yearly Dividend6.1
Dividend Growth(5Y)11.16%
DP182.75%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-04 2025-08-04 (1.03)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.84%
Min EPS beat(2)0.65%
Max EPS beat(2)7.03%
EPS beat(4)4
Avg EPS beat(4)6.66%
Min EPS beat(4)0.65%
Max EPS beat(4)12.43%
EPS beat(8)5
Avg EPS beat(8)2.96%
EPS beat(12)7
Avg EPS beat(12)2.84%
EPS beat(16)11
Avg EPS beat(16)8.35%
Revenue beat(2)1
Avg Revenue beat(2)3.38%
Min Revenue beat(2)-0.22%
Max Revenue beat(2)6.98%
Revenue beat(4)2
Avg Revenue beat(4)2.44%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)6.98%
Revenue beat(8)2
Avg Revenue beat(8)-1.46%
Revenue beat(12)2
Avg Revenue beat(12)-13.7%
Revenue beat(16)5
Avg Revenue beat(16)7.59%
PT rev (1m)12.42%
PT rev (3m)23.7%
EPS NQ rev (1m)0.43%
EPS NQ rev (3m)-16%
EPS NY rev (1m)3.94%
EPS NY rev (3m)4.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.19%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)2.79%
Valuation
Industry RankSector Rank
PE 33.86
Fwd PE 25.16
P/S 14.59
P/FCF 61.15
P/OCF 59.33
P/B 24.02
P/tB 31.76
EV/EBITDA 29.5
EPS(TTM)5
EY2.95%
EPS(NY)6.73
Fwd EY3.97%
FCF(TTM)2.77
FCFY1.64%
OCF(TTM)2.85
OCFY1.69%
SpS11.6
BVpS7.05
TBVpS5.33
PEG (NY)2.81
PEG (5Y)2.26
Profitability
Industry RankSector Rank
ROA 6.31%
ROE 34.29%
ROCE 21.17%
ROIC 17.66%
ROICexc 19.13%
ROICexgc 20.63%
OM 50.95%
PM (TTM) 20.83%
GM N/A
FCFM 23.86%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
ROICexc(3y)14.24%
ROICexc(5y)19.2%
ROICexgc(3y)15.53%
ROICexgc(5y)21.12%
ROCE(3y)15.37%
ROCE(5y)21.01%
ROICexcg growth 3Y-21.19%
ROICexcg growth 5Y9.44%
ROICexc growth 3Y-21.05%
ROICexc growth 5Y9.86%
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 3.66
Debt/EBITDA 1.71
Cap/Depr 280.1%
Cap/Sales 0.73%
Interest Coverage 14.47
Cash Conversion 48.02%
Profit Quality 114.54%
Current Ratio 0.7
Quick Ratio 0.7
Altman-Z 3.94
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)360.42%
Cap/Depr(5y)264.86%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.63%
Profit Quality(3y)249.28%
Profit Quality(5y)197.86%
High Growth Momentum
Growth
EPS 1Y (TTM)25.31%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%26.04%
EPS Next Y12.05%
EPS Next 2Y20.43%
EPS Next 3Y21.88%
EPS Next 5Y12.53%
Revenue 1Y (TTM)33.33%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%22.18%
Revenue Next Year9.27%
Revenue Next 2Y18%
Revenue Next 3Y19.89%
Revenue Next 5Y15.92%
EBIT growth 1Y39.89%
EBIT growth 3Y-19.82%
EBIT growth 5Y13.91%
EBIT Next Year9.21%
EBIT Next 3Y22.86%
EBIT Next 5Y6.22%
FCF growth 1Y-6.6%
FCF growth 3Y-4.46%
FCF growth 5Y12.44%
OCF growth 1Y-10.47%
OCF growth 3Y-4.41%
OCF growth 5Y12.14%